Recombinant multi-species Galectin 8/LGALS8 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Galectin 8/LGALS8 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the galectin family. Galectins are beta-galactoside-binding animal lectins with conserved carbohydrate recognition domains. The galectins have been implicated in many essential functions including development, differentiation, cell-cell adhesion, cell-matrix interaction, growth regulation, apoptosis, and RNA splicing. This gene is widely expressed in tumoral tissues and seems to be involved in integrin-like cell interactions. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 1200015E08Rik,D13Ertd524e,Gal-8,Galectin 8,Galectin-8,LGALS8,Lgals-8,Lgals8,PCTA-1,PCTA1,Po66 carbohydrate-binding protein (Po66-CBP),Po66-CBP,Prostate carcinoma tumor antigen 1 (PCTA-1),galectin-8

Target products collectionGo to Galectin 8/LGALS8 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP2573-Ag-1/ GM-Tg-hg-IP2573-Ag-2 Human Galectin 8/LGALS8 protein Human
GM-Tg-rg-IP2573-Ag-1/ GM-Tg-rg-IP2573-Ag-2 Rat Galectin 8/LGALS8 protein Rat
GM-Tg-mg-IP2573-Ag-1/ GM-Tg-mg-IP2573-Ag-2 Mouse Galectin 8/LGALS8 protein Mouse
GM-Tg-cynog-IP2573-Ag-1/ GM-Tg-cynog-IP2573-Ag-2 Cynomolgus/Rhesus macaque Galectin 8/LGALS8 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP2573-Ag-1/ GM-Tg-felg-IP2573-Ag-2 Feline Galectin 8/LGALS8 protein Feline
GM-Tg-cang-IP2573-Ag-1/ GM-Tg-cang-IP2573-Ag-2 Canine Galectin 8/LGALS8 protein Canine
GM-Tg-bovg-IP2573-Ag-1/ GM-Tg-bovg-IP2573-Ag-2 Bovine Galectin 8/LGALS8 protein Bovine
GM-Tg-equg-IP2573-Ag-1/ GM-Tg-equg-IP2573-Ag-2 Equine Galectin 8/LGALS8 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP2573-Ag-1/ GM-Tg-hg-IP2573-Ag-2; GM-Tg-rg-IP2573-Ag-1/ GM-Tg-rg-IP2573-Ag-2;
GM-Tg-mg-IP2573-Ag-1/ GM-Tg-mg-IP2573-Ag-2; GM-Tg-cynog-IP2573-Ag-1/ GM-Tg-cynog-IP2573-Ag-2;
GM-Tg-felg-IP2573-Ag-1/ GM-Tg-felg-IP2573-Ag-2; GM-Tg-cang-IP2573-Ag-1/ GM-Tg-cang-IP2573-Ag-2;
GM-Tg-bovg-IP2573-Ag-1/ GM-Tg-bovg-IP2573-Ag-2; GM-Tg-equg-IP2573-Ag-1/ GM-Tg-equg-IP2573-Ag-2
Products Name Galectin 8/LGALS8 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name Galectin 8/LGALS8
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Galectin 8/LGALS8 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.